TY - JOUR
T1 - Effect of tumor promoters on lipid peroxidation in mouse skin
AU - Logani, M. K.
AU - Solanki, V.
AU - Slaga, T. J.
N1 - Funding Information:
Research supported by the Office of Health and Environmental Research, U.S. Department of Energy, under contract W-7405-eng-25 with the Union Carbide Corporation. V.Solanld is a postdoctoral investigator supported by Subcontract No. 3322 from the Biology Division of Oak Ridge National Laboratory to the University of Tennessee.
PY - 1982
Y1 - 1982
N2 - Products of lipid peroxidation were measured in mouse epidermis. These were shown to increase with advancing age. Conversely, a decline in these products was observed on treatment with 12-O-tetradecanoylphorbol-13-acetate (TPA), a potent tumor promoting agent. A decline in lipid peroxidation occured within 4 h after application of 2 μg TPA and the maximum effect was seen at 22-24 h. A lesser active tumor promoter, phorbol dibenzoate; and ethyl phenylpro-piolate, a purely hyperplastic agent, also lowered lipid peroxidation; while phorbol, a non-promoter, did not show any significant effect. Mezerein, a resiniferonal derivative with weak promoting activity but a potent stage II promoter, appeared to be more potent than TPA in lowering the basal levels of peroxidation. The TPA-induced decrease in lipid peroxidation could be prevented by fluocinolone acetonide, a potent antipromoting and antimitotic agent, but not by retinoic acid and tosylamino-2-phenylethylchloromethyl-ketone which are relatively potent antipromoting agents but lack antimitotic activity, suggesting that the decrease of lipid peroxidation by tumor promoting agents is possibly related to their mitotic activity. Furthermore, skin papilloma and carcinoma contain lower levels of lipid peroxidation compared to epidermis from the same mice.
AB - Products of lipid peroxidation were measured in mouse epidermis. These were shown to increase with advancing age. Conversely, a decline in these products was observed on treatment with 12-O-tetradecanoylphorbol-13-acetate (TPA), a potent tumor promoting agent. A decline in lipid peroxidation occured within 4 h after application of 2 μg TPA and the maximum effect was seen at 22-24 h. A lesser active tumor promoter, phorbol dibenzoate; and ethyl phenylpro-piolate, a purely hyperplastic agent, also lowered lipid peroxidation; while phorbol, a non-promoter, did not show any significant effect. Mezerein, a resiniferonal derivative with weak promoting activity but a potent stage II promoter, appeared to be more potent than TPA in lowering the basal levels of peroxidation. The TPA-induced decrease in lipid peroxidation could be prevented by fluocinolone acetonide, a potent antipromoting and antimitotic agent, but not by retinoic acid and tosylamino-2-phenylethylchloromethyl-ketone which are relatively potent antipromoting agents but lack antimitotic activity, suggesting that the decrease of lipid peroxidation by tumor promoting agents is possibly related to their mitotic activity. Furthermore, skin papilloma and carcinoma contain lower levels of lipid peroxidation compared to epidermis from the same mice.
UR - http://www.scopus.com/inward/record.url?scp=0020442842&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0020442842&partnerID=8YFLogxK
U2 - 10.1093/carcin/3.11.1303
DO - 10.1093/carcin/3.11.1303
M3 - Article
C2 - 7151249
AN - SCOPUS:0020442842
VL - 3
SP - 1303
EP - 1306
JO - Carcinogenesis
JF - Carcinogenesis
SN - 0143-3334
IS - 11
ER -